Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.7.0 is added to the study record history, and the prior entry v3.6.6 is removed, reflecting an update to the page’s version history.SummaryDifference0.0%

- Check35 days agoChange DetectedAn entry 'Revision: v3.6.6' was added to the study's history page. The previous 'Revision: v3.6.5' entry and the 'References' section were removed, reflecting an update to the record's version history.SummaryDifference0.1%

- Check57 days agoChange DetectedThe history list shows the page revision updated from v3.6.4 to v3.6.5, indicating a new version of the page. The update is limited to the version label and does not affect content.SummaryDifference0.0%

- Check71 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the history. The previous Revision: v3.6.3 entry was removed.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page history revision label advanced from v3.6.2 to v3.6.3, indicating a new version of the page has been released.SummaryDifference0.0%

- Check100 days agoChange DetectedA new revision entry, Revision: v3.6.2, has been added to the Study Record History, replacing Revision: v3.6.0. This indicates a minor platform update to the history view.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.